Clarity Pharmaceuticals is trading at 3.00 as of the 14th of December 2024. This is a 3.54 percent decrease since the beginning of the trading day. The stock's lowest day price was 3.0. Clarity Pharmaceuticals has hardly any chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 14th of November 2024 and ending today, the 14th of December 2024. Click here to learn more.
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Clarity Pharmaceuticals pink sheet to make a market-neutral strategy. Peer analysis of Clarity Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Clarity Pharmaceuticals by comparing valuation metrics with similar companies.